F-star Therapeutics Appoints James Sandy as Chief Development Officer

Go back to F-star Therapeutics Appoints James Sandy as Chief Development Officer
(NASDAQ: FSTX) Delayed: 7.12 --0 (-0%)
Previous Close $7.12    52 Week High
Open $12.36    52 Week Low
Day High $7.12    P/E N/A 
Day Low $7.12    EPS
Volume 1,067,673